Home > Boards > US OTC > Biotechs >

Q BioMed Inc. (QBIO)

Add QBIO Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 10/8/2019 7:20:44 PM - Followers: 22 - Board type: Free - Posts Today: 0

Q Biomed Inc.

Welcome to Q

Q BioMed Inc. is a biomedical acceleration and development company. We are dedicated to acquiring and providing strategic resources and expansion capital to innovative healthcare companies that strive to provide much needed healthcare and related products to patients in need. By partnering with exceptional entrepreneurs we aim to help to create market-leading products and companies in the biomedical and healthcare sector. As entrepreneurs and investors with operational and technical expertise we embrace a collaborative approach to capital formation and business development.

Why Q BioMed

Through Q BioMed investors have the opportunity to invest in some of the most innovative bio-medical products that they may never have known about. Technologies are vetted by analysts, industry KOLs and experts. Your investment is in Q BioMed  – so you have public company liquidity without being tied up in a private company with an unknown exit strategy and uncertain value inflection milestones (FDA etc).

Q BioMed aims to mitigate risk by having multiple relationships and assets across a broad spectrum of healthcare companies and sectors. Success being shared as multiple assets mature at different times in their development cycle passing on value to the Q BioMed shareholders.


Q has the ability to fund and/or acquire promising BioMedical assets. We use management’s expertise and network of experts to evaluate undervalued assets and to secure an equity interest in promising technologies and products. We help develop them into high value businesses. Q and its investors will benefit from early positioning in largely illiquid and unknown private assets with multiple potential products and their development cycle and valuation growth as they move forward. By structuring the company to keep overhead to a minimum and costs down there is limited burn and significant upside potential as assets progress through their development cycle.


Q BioMed Inc is assessing multiple BioMedical assets in various areas of healthcare and drug development. Our Pipeline is not complete and not yet formalized. We are actively pursuing a pipeline of therapeutics, diagnostics and orphan drug candidates that we believe will provide a robust technology platform from which to build significant value.

Management and Directors

Denis D Corin - President and DirectorMr. Denis D. Corin is our President and a director. Mr. Corin is an experienced public company executive and management consultant. He has worked almost exclusively in the biomedical field for over 13 years from large pharma and diagnostic companies to small innovative biotech. He has served in various senior executive roles and has been instrumental is building and restructuring businesses. Mr. Corin has raised millions of dollars in development capital to advance businesses. Mr. Corin also serves as a Management Consultant to the executives and board of TapImmune Inc., a clinical stage immune-oncology company where had previously served as CEO and President. He has been a Director of Q BioMed, Inc. since April 2015. He served as a Director of TapImmune Inc., from July 2009 to May 2012. He continues to serve as a Director of Soloro Gold and NPX Metals Inc. He holds a Bachelors Degree majoring in both Economics and Marketing & Advertising Management from the University of Natal, South Africa.

William Rosenstadt - General and Corporate Securities Counsel and DirectorWilliam Rosenstadt is the founding and managing partner of Sanders Ortoli Vaughn-Flam Rosenstadt LLP an international law firm located in New York and has been a practicing attorney since 1995. William advises entrepreneurs, public companies, and other corporate entities with respect to the execution of complex commercial, corporate, and international transactions. William often serves as general counsel to his clients advising them with respect to public and private financings (equity and debt), federal securities law compliance and other merger and acquisition related transactions. Mr. Rosenstadt and his firm are authorized to sponsor issuers on the OTC Markets as Principal American Liaisons (“PAL”) and Designated Advisors for Disclosure (“DAD”) and were instrumental in introducing the Canadian Securities Exchange to the OTC Markets and having it designated as an authorized exchange. Early in his legal career, Mr. Rosenstadt was general counsel to American Industrial Acquisition Corporation, a private equity firm focused on investing in privately held, middle market manufacturers in the wire/cable and defense industries. Mr. Rosenstadt graduated from Syracuse University with a B.A. in 1990 and received his J.D. from the Benjamin N. Cardozo School of Law in 1995. Further, he is admitted to the bars of New York, New Jersey, and Connecticut as well as the Second Circuit of the federal courts of the United States.

Ari Jatwes - Corporate Advisor and Senior Analyst - Ari Jatwes is an analyst and a banker, with over twenty years of experience. He began his career in a large accounting firm, progressing to a reputable investment bank, where he gained his tremendous experience in mergers and acquisitions. Over the last decade Ari’s interest and focus has been in the biotech and pharma sector, which included trading biotech stocks from start up to late stage biotech companies, advising management and raising capital for their needs. Ari has played an integral role in several successful contracts and transactions in the healthcare space - with emphasis on the life sciences and immunotherapy. Mr. Jatwes holds two Master degrees and a Bachelor Degree from the University of South Africa and the University of Natal.

David Laskow-Pooley - VP Scientific & Product Development - Mr. Laskow-Pooley has 30 years of experience in all aspects of the discovery, development and commercialization of pharmaceutical products, diagnostics and devices. He is an industry veteran and has a distinguished career working for numerous pharmaceutical and life sciences companies. David has held director, executive officer and general management posts in both small and major multinational companies including GSK, Abbott, Amersham plc, Life technologies, OSI, Bilcare and Surface Therapeutics.

Capital Structure

Shares Issued: 9,250,000

Management/Insider Ownership: 3,2 M (35%)

Warrants: 1,000,000

Authorized: 250,000,000 Common, 100,000,000 Preferred

Q Biomed Inc.

Q Biomed Inc.
A Biotechnology Acceleration Company

501 Madison Ave, 14th Floor
New York, NY 10022
Phone: +1 (888) 357-2435
Email: info@qbiomed.com

Website: www.qbiomed.com


Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
QBIO News: Current Report Filing (8-k) 09/26/2019 08:30:59 AM
QBIO News: Current Report Filing (8-k) 09/10/2019 05:02:08 PM
QBIO News: Amended Current Report Filing (8-k/a) 09/06/2019 02:16:36 PM
QBIO News: Current Report Filing (8-k) 09/04/2019 05:24:46 PM
QBIO News: Quarterly Report (10-q) 07/19/2019 05:12:55 PM
#836   QBIO....great time to buy at these levels,can easily Thunderstruck 10/08/19 07:20:44 PM
#835   Someone is pushing this down I think a Chrism0000 10/08/19 06:15:51 PM
#834   QBIO...Nice slaps hitting now. Bit of a turn? Thunderstruck 10/08/19 12:34:31 PM
#833   takes alot of balls to short a 9 chuck29 10/07/19 04:39:31 PM
#832   I noticed lol shorts have a hold? Chrism0000 10/07/19 03:24:04 PM
#831   there selling off this stock again wow chuck29 10/07/19 03:11:00 PM
#830   THANKS!! Chrism0000 10/04/19 04:32:52 PM
#829   look at all these fools selling with a chuck29 10/04/19 04:28:09 PM
#828   go to twitter and then go to the chuck29 10/04/19 04:27:20 PM
#827   No do u have a link to send? Thanks Chrism0000 10/04/19 04:25:04 PM
#826   did you see the video this morning with chuck29 10/04/19 04:13:05 PM
#825   LOL keep selling morons!! Chrism0000 10/04/19 02:22:34 PM
#824   Goodmorning QBIO LETS HAVE ANOTHER GREAT DAY!! :) Chrism0000 10/04/19 08:25:17 AM
#823   TD and Charles schwab dropping there trading fees Chrism0000 10/03/19 05:09:57 PM
#822   just went to the arcview group twitter page chuck29 10/03/19 04:51:14 PM
#821   Absolutely! Some of my family owns it also. Thunderstruck 10/03/19 04:48:02 PM
#820   Made only 500$ bucks today but hey more Chrism0000 10/03/19 04:37:37 PM
#819   Lets do this again Tomorrow!! :) Chrism0000 10/03/19 04:36:47 PM
#818   this is a monster gaining momentum. going up chuck29 10/03/19 04:26:11 PM
#817   even at .80 cents this is still a bargain chuck29 10/03/19 04:23:12 PM
#816   they will try but the low float is chuck29 10/03/19 04:22:18 PM
#815   QBIO...NICE!! Thunderstruck 10/03/19 01:59:25 PM
#814   Picked up 2000 total Chrism0000 10/03/19 01:55:15 PM
#813   QBIO...HUGE SLAP!!!!! @.76!!! Thunderstruck 10/03/19 01:48:56 PM
#812   QBIO....Looks like judging from level 2 Many MM's Thunderstruck 10/03/19 01:27:46 PM
#811   Shorts and profit scum messing with us today!! grrrr Chrism0000 10/03/19 11:59:04 AM
#810   QBIO...I don't believe they can hold it down Thunderstruck 10/03/19 10:12:10 AM
#809   Incredible...When ya take a look @ the tape!!! Thunderstruck 10/03/19 10:10:43 AM
#808   MM's trying to keep it down Chrism0000 10/03/19 10:09:07 AM
#807   QBIO...Many buy orders getting filled!! Thunderstruck 10/03/19 10:00:44 AM
#806   Monster News today! Golden_Cross 10/03/19 09:33:50 AM
#805   QBIO!!! Agree!!! Thunderstruck 10/03/19 09:27:27 AM
#804   QBIO!!!! Huge!!!!! Thunderstruck 10/03/19 09:26:46 AM
#803   HUGE news last 2 days...could VERY easily see bullstocker 10/03/19 09:24:35 AM
#802   RSI popped out of oversold territory and the Golden_Cross 10/03/19 08:34:56 AM
#801   QBIO Daily Chart...nice bounce yesterday Golden_Cross 10/03/19 08:33:08 AM
#800   News - Q BioMed Announces Commercial Partnership With Golden_Cross 10/03/19 08:32:11 AM
#799   Potentially go back almost to $2 if we're lucky Chrism0000 10/02/19 10:42:45 PM
#798   you still think there number is up. ? chuck29 10/02/19 10:15:47 PM
#797   what a monster announcement. this could skyrock once chuck29 10/02/19 05:25:44 PM
#796   Bought 1500 shares to test the waters. Chrism0000 10/02/19 03:39:10 PM
#795   Loaded the boat... bullstocker 10/02/19 02:41:28 PM
#794   QBIO...Added at these levels!! Thunderstruck 10/01/19 12:23:29 PM
#793   Throw, not through!! For Christs sakes steamingstockpile 09/27/19 05:48:07 PM
#792   When it goes in the 30s I might steamingstockpile 09/27/19 05:47:33 PM
#791   The 8-k was just put out yesterday. There Thunderstruck 09/27/19 05:38:36 PM
#790   Call that number, press 1,2,3,4 when it answers, steamingstockpile 09/27/19 05:18:02 PM
#789   QBIO...CONTACT INFO. THEY ARE THERE!!!!!! Thunderstruck 09/27/19 05:02:34 PM
#788   QBIO...Q BioMed Stock Price, News & Analysis (OTCMKTS:QBIO) Thunderstruck 09/27/19 04:58:14 PM
#787   QBIO....Q BioMed Announces Updates on Commercialization of Non-Opioid Thunderstruck 09/27/19 04:55:34 PM